A review highlighted how metabolism-focused re-engineering could address CAR-T’s performance limitations in solid tumors, where nutrient and microenvironment constraints can blunt T-cell function. The article discusses strategies aimed at rewiring metabolic pathways to improve persistence and activity while confronting the suppressive tumor milieu.